LavaroniG., KokeljF., PauluzziP., TrevisanG.The nails in psoriatic arthritis. Acta Derm Venereol.1994; 186: suppl: 113.
2.
RichP.Nail disorders. Diagnosis and treatment of infectious, inflammatory, and neoplastic nail conditions. Med Clin North Am.1998; 82: 1171–83.
3.
JongdeEMGJ, SeegersBAMPA, GulinckM.K., BoezemanJ.B.M., Kerkhof van deP.C.M.Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,782 patients. Dermatology.1996; 193: 300–3.
4.
JensenH.A., MikkelsenH.I., WadskovS., SondegaardJ.Cutaneous reactions due to propranolol. Acta Med Scand.1976; 199: 363.
5.
TegnerE.Reversible overcurvature of the nails after treatment with practolol. Acta Derm Venereol1976; 56: 493.
6.
RudolphR.I.Lithium-induced psoriasis of the fingernails. J Am Acad Dermatol.1992; 26: 135.
7.
De BerkerD.Diagnosis and management of nail psoriasis. Dermatol Ther2002; 15: 165–72.
8.
BaranR., TostiA.Topical treatment of nail psoriasis with a new corticosteroid-containing nail lacquer formulation. J Derm Treat.1999; 10: 201–4.
9.
TostiA.Piraccini BM, Cameli N, Kokely F, Plozzer C, Cannata GE, Benelli C. Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid. Br J Dermatol.1998; 139: 655–9.
FelicianiC., ZampettiA., ForleoP., Cerritelli, AmerioP., ProiettoG., TulliA., AmerioP.Nail psoriasis: Combined therapy with systemic cyclosporin and topical calcipotriol. J Cutan Med Surg.2004; May 3: online.
12.
FritzK.Successful topical treatment of nail psoriasis with 5-fluorouracil. Z Hautkr.1989; 64: 1083–8.
13.
FredrikssonT.Topical applied fluorouracil in the treatment of psoriatic nails. Arch Dermatol.1974; 110: 735–6.
14.
GoldmanL., BlaneyD.J., CohenW.Onychodystrophy after topical 5-fluorouracil. Arch Dermatol.1963; 88: 529.
15.
YamamotoT., KatayamaI., NishiokaK.Topical anthralin therapy for refractory nail psoriasis. J Dermatol.1998; 25: 231–3.
16.
Laborde vanS., ScherR.K.Developments in the treatment of nail psoriasis, melanonychia striata, and onychomycosis. A review of the literature. Dermatol Clin.2000; 18: 37–46.
17.
ScherR.K., StillerM., ZhuY.I.Tazarotene 0.1% gel in the treatment of fingernail psoriasis: A double blind, randomized, vehicle-controlled study. Cutis.2001; 68: 355–8.
18.
TostiA., GuerraL., BardazziF.Topical ciclosporin in nail psoriasis (Letter). Dermatologica.1990; 180: 110.
19.
CannavoS.P., GuarneriF., VaccaroM., BorgiaF., GuarneriB.Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study. Dermatology.2003; 208: 153–6.
20.
De BerkerD.A., LawrenceC.M.A simplified protocol of steroid injection for psoriatic nail dystrophy. Br J Dermatol.1998; 138: 90–5.
21.
De BerkerD.A.Phenolic ablation of the nail matrix. Australas J Dermatol.2001; 42: 59–61.
22.
HoffmanC., PlewigG., Braun-FalcoO.Photo-chemotherapy of nail psoriasis. Int Psoriasis Bull.1977; 4: 3.
23.
ParkerS.G., DiffeyB.L.The transmission of optical radiation through human nail. Br J Dermatol.1983; 108: 11–16.
24.
LindelöfB.Psoriasis of the nails treated with Grenz rays: a double-blind bilateral trial. Acta Derm Venereol.1988/9; 69: 80–2.
25.
YuR.C., KingC.M.A double-blind study of superficial radiotherapy in psoriatic nail dystrophy. Acta Derm Venereol.1992; 72: 134–6.
26.
KwangT.Y., NeeT.S., SengK.T.H.A therapeutic study of nail psoriasis using electron beams. (Letter). Acta Derm Venereol.1994; 75: 90.
27.
BaranR.Retinoids and the nails. J Derm Treat.1990; 1: 151–54.
28.
MahrleG., SchulzeH-J, FärberL., WeidingerG., SteiglederG.K.Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement. J Am Acad Dermatol.1995; 32: 78–88.
29.
NyforsA.Benefits and adverse drug experiences during long-term methotrexate treatment in 248 psoriatics. Dan Med Bull.1978; 25: 208–11.
